122 related articles for article (PubMed ID: 28242417)
21. Cholesterol in situ forming gel loaded with doxycycline hyclate for intra-periodontal pocket delivery.
Phaechamud T; Setthajindalert O
Eur J Pharm Sci; 2017 Mar; 99():258-265. PubMed ID: 28027940
[TBL] [Abstract][Full Text] [Related]
22. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants.
Thakur RR; McMillan HL; Jones DS
J Control Release; 2014 Feb; 176():8-23. PubMed ID: 24374003
[TBL] [Abstract][Full Text] [Related]
23. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment.
Agossa K; Lizambard M; Rongthong T; Delcourt-Debruyne E; Siepmann J; Siepmann F
Int J Pharm; 2017 Apr; 521(1-2):282-293. PubMed ID: 28223246
[TBL] [Abstract][Full Text] [Related]
24. Controlled release of Doxycycline from gum acacia/poly(sodium acrylate) microparticles for oral drug delivery.
Bajpai SK; Jadaun M; Bajpai M; Jyotishi P; Shah FF; Tiwari S
Int J Biol Macromol; 2017 Nov; 104(Pt A):1064-1071. PubMed ID: 28668612
[TBL] [Abstract][Full Text] [Related]
25. The role of local drug delivery in the treatment of chronic periodontitis. Things you should know.
Greenstein G
Dent Today; 2004 Mar; 23(3):110-5. PubMed ID: 15060919
[No Abstract] [Full Text] [Related]
26. In situ forming implants for periodontitis treatment with improved adhesive properties.
Do MP; Neut C; Delcourt E; Seixas Certo T; Siepmann J; Siepmann F
Eur J Pharm Biopharm; 2014 Oct; 88(2):342-50. PubMed ID: 24833006
[TBL] [Abstract][Full Text] [Related]
27. Preparation of polylactic acid microcapsules containing ciprofloxacin.
Yu WP; Wong JP; Chang TM
J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
[TBL] [Abstract][Full Text] [Related]
28. Doxycycline hyclate-loaded bleached shellac in situ forming microparticle for intraperiodontal pocket local delivery.
Phaechamud T; Chanyaboonsub N; Setthajindalert O
Eur J Pharm Sci; 2016 Oct; 93():360-70. PubMed ID: 27552903
[TBL] [Abstract][Full Text] [Related]
29. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
[TBL] [Abstract][Full Text] [Related]
30.
Dubar M; Lizambard M; Delcourt-Debruyne E; Batool F; Huck O; Siepmann F; Agossa K
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34500442
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional poly(β-amino ester) hydrogel microparticles in periodontal in situ forming drug delivery systems.
Fisher PD; Clemens J; Zach Hilt J; Puleo DA
Biomed Mater; 2016 Mar; 11(2):025002. PubMed ID: 26947556
[TBL] [Abstract][Full Text] [Related]
32. New treatments hold perio promise.
Jones DG
J Calif Dent Assoc; 1998 Dec; 26(12):882-4. PubMed ID: 10388438
[No Abstract] [Full Text] [Related]
33. Chitosan inserts for periodontitis: influence of drug loading, plasticizer and crosslinking on in vitro metronidazole release.
Barat R; Srinatha A; Pandit JK; Anupurba S; Mittal N
Acta Pharm; 2007 Dec; 57(4):469-77. PubMed ID: 18165190
[TBL] [Abstract][Full Text] [Related]
34. Controlled local delivery of antimicrobials in the treatment of periodontitis.
Killoy WJ; Polson AM
Dent Clin North Am; 1998 Apr; 42(2):263-83. PubMed ID: 9597337
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable dental implants of ciprofloxacin beta-cyclodextrin inclusion complex in the treatment of periodontitis.
Nagaraju R; Udupa N; Mathew J; Varma BR
Indian J Exp Biol; 1999 Mar; 37(3):305-7. PubMed ID: 10641162
[TBL] [Abstract][Full Text] [Related]
36. Local delivery of antimicrobial agents for the treatment of periodontitis.
Magnusson I
Compend Contin Educ Dent; 1998 Oct; 19(10):953-6; 958, 960 passim quiz 966. PubMed ID: 10371879
[TBL] [Abstract][Full Text] [Related]
37. [Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers].
Gander B; Gurny R; Doelker E
Pharm Acta Helv; 1986; 61(5-6):130-4. PubMed ID: 3725810
[No Abstract] [Full Text] [Related]
38. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
[TBL] [Abstract][Full Text] [Related]
39. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
[TBL] [Abstract][Full Text] [Related]
40. Local and Sustained Activity of Doxycycline Delivered with Layer-by-Layer Microcapsules.
Luo D; Gould DJ; Sukhorukov GB
Biomacromolecules; 2016 Apr; 17(4):1466-76. PubMed ID: 26967921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
